‘Decision to use Pfizer-BioNTech vaccine up to NPRA’


The Health Ministry’s National Pharmaceutical Regulatory Agency (NPRA) has received the clinical data on the Covid-19 vaccine from Pfizer-BioNTech, says Khairy Jamaluddin.

The Science, Technology and Innovations Minister said the decision to use the vaccine from the company lies with NPRA and the Health Ministry upon the completion of the registration and approval process.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Nation

Anwar undertakes one-day working visit to Penang, Kedah
Irregular immigration stamping affects national security, says Immigration DG
MACC investigating alleged RM300mil investment fraud involving Tan Sri
MACC remands two people, including a senior Navy officer, in RM2mil corruption case
LiveBlog: Voter turnout reaches 12.54% in Kinabatangan, 10.57% in Lamag by 9am, says the EC
Test of loyalty in by-election
Ringgit rise expected to continue�
SMG retains gold for third year
Parents and travellers revising currency strategies
Student who fights to breathe gets aid from PM

Others Also Read